Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

214 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting.
Aristei C, Bölükbaşı Y, Kaidar-Person O, Pfeffer R, Arenas M, Boersma LJ, Ciabattoni A, Coles CE, Franco P, Krengli M, Leonardi MC, Marazzi F, Masiello V, Meattini I, Montero A, Offersen B, Trigo ML, Bourgier C, Genovesi D, Kouloulias V, Morganti AG, Meduri B, Pasinetti N, Pedretti S, Perrucci E, Rivera S, Tombolini V, Vidali C, Valentini V, Poortmans P. Aristei C, et al. Among authors: krengli m. Crit Rev Oncol Hematol. 2022 Sep;177:103774. doi: 10.1016/j.critrevonc.2022.103774. Epub 2022 Jul 30. Crit Rev Oncol Hematol. 2022. PMID: 35917884 Review.
Curative external beam radiotherapy in patients over 80 years of age with localized prostate cancer: a retrospective rare cancer network study.
Nguyen TD, Azria D, Brochon D, Poortmans P, Miller RC, Scandolaro L, Majewski W, Krengli M, Abacioglu U, Moretti L, Villa S, Akyol F, Jovenin N. Nguyen TD, et al. Among authors: krengli m. Crit Rev Oncol Hematol. 2010 Apr;74(1):66-71. doi: 10.1016/j.critrevonc.2009.04.004. Epub 2009 May 5. Crit Rev Oncol Hematol. 2010. PMID: 19419885
Dose per fraction and dose rate effect.
Franco P, Beldì D, Krengli M. Franco P, et al. Among authors: krengli m. Tumori. 2010 May-Jun;96(3):512; author reply 512-3. doi: 10.1177/030089161009600325. Tumori. 2010. PMID: 20845820 No abstract available.
Clinical and technical characteristics of intraoperative radiotherapy. Analysis of the ISIORT-Europe database.
Krengli M, Calvo FA, Sedlmayer F, Sole CV, Fastner G, Alessandro M, Maluta S, Corvò R, Sperk E, Litoborski M, Pisani C, Fillini C, Fusconi F, Osti MF, Tomio L, Marsiglia H, Ciabattoni A, Polkowski W, Di Grazia A, Gava A, Kuten A, Iotti C, Gonzalez C, Sallabanda M, Dubois JB, Catalano G, Valentini V. Krengli M, et al. Strahlenther Onkol. 2013 Sep;189(9):729-37. doi: 10.1007/s00066-013-0395-1. Epub 2013 Jul 12. Strahlenther Onkol. 2013. PMID: 23842635
Could machine learning improve the prediction of pelvic nodal status of prostate cancer patients? Preliminary results of a pilot study.
De Bari B, Vallati M, Gatta R, Simeone C, Girelli G, Ricardi U, Meattini I, Gabriele P, Bellavita R, Krengli M, Cafaro I, Cagna E, Bunkheila F, Borghesi S, Signor M, Di Marco A, Bertoni F, Stefanacci M, Pasinetti N, Buglione M, Magrini SM. De Bari B, et al. Among authors: krengli m. Cancer Invest. 2015 Jul;33(6):232-40. doi: 10.3109/07357907.2015.1024317. Epub 2015 May 7. Cancer Invest. 2015. PMID: 25950849
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial.
Pedretti S, Masini L, Turco E, Triggiani L, Krengli M, Meduri B, Pirtoli L, Borghetti P, Pegurri L, Riva N, Gatta R, Fusco V, Scoccianti S, Bruni A, Ricardi U, Santoni R, Magrini SM, Buglione M. Pedretti S, et al. Among authors: krengli m. J Neurooncol. 2019 Jul;143(3):447-455. doi: 10.1007/s11060-019-03175-2. Epub 2019 May 4. J Neurooncol. 2019. PMID: 31054101 Clinical Trial.
214 results